Showing results (141-150 of 185) with videos related to

Sort By:
Pageof 19
Cellular and Molecular Life Sciences : CMLS|January 10, 2024
Delineating the mechanism of fragility at BCL6 breakpoint region associated with translocations in diffuse large B cell lymphomaVidya Gopalakrishnan, Urbi Roy, Shikha Srivastava, et al.
Scientific Reports|September 17, 2020
Acute toxicity analysis of Disarib, an inhibitor of BCL2Shivangi Sharma, Kontham Kulangara Varsha, Susmita Kumari, et al.
The FEBS Journal|September 1, 2022
Identification and characterization of mercaptopyrimidine-based small molecules as inhibitors of nonhomologous DNA end joiningUjjayinee Ray, Vindya K Gopinatha, Shivangi Sharma, et al.
Scientific Reports|May 12, 2021
Acute toxicity analysis of an inhibitor of BCL2, Disarib, in ratsShivangi Sharma, Kontham Kulangara Varsha, Ujjayinee Ray, et al.
Journal of Cancer|July 11, 2022
Peroxiredoxins - Urinary Surveillance Biomarkers in Urothelial CancerNitu Kumari, Pawan Vasudeva, Pranay Tanwar, et al.
The FEBS Journal|September 20, 2018
Autocyclized and oxidized forms of SCR7 induce cancer cell death by inhibiting nonhomologous DNA end joining in a Ligase IV dependent mannerSupriya V Vartak, Hassan A Swarup, Vidya Gopalakrishnan, et al.
Nucleic Acids Research|October 1, 2010
Formation of a G-quadruplex at the BCL2 major breakpoint region of the t(14;18) translocation in follicular lymphomaMridula Nambiar, G Goldsmith, Balaji T Moorthy, et al.
ACS Omega|November 6, 2023
Block Copolymer Encapsulation of Disarib, an Inhibitor of BCL2 for Improved Chemotherapeutic PotentialReshma Joy, Humaira Siddiqua, Shivangi Sharma, et al.
Pageof 19